1. Home
  2. HALO vs RTO Comparison

HALO vs RTO Comparison

Compare HALO & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$100.98

Market Cap

14.8B

Sector

Health Care

ML Signal

N/A

Logo Rentokil Initial plc

RTO

Rentokil Initial plc

N/A

Current Price

$23.70

Market Cap

12.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
RTO
Founded
1998
1925
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
12.0B
IPO Year
2001
2002

Fundamental Metrics

Financial Performance
Metric
HALO
RTO
Price
$100.98
$23.70
Analyst Decision
Buy
Buy
Analyst Count
9
4
Target Price
★ $119.89
$30.70
AVG Volume (30 Days)
★ 2.3M
1.6M
Earning Date
11-05-2026
07-30-2026
Dividend Yield
N/A
★ 2.29%
EPS Growth
N/A
★ N/A
EPS
★ 5.12
N/A
Revenue
★ $151,862,000.00
N/A
Revenue This Year
$35.97
$4.77
Revenue Next Year
$14.85
$2.90
P/E Ratio
★ $19.84
$222.16
Revenue Growth
N/A
N/A
52 Week Low
$61.23
$19.50
52 Week High
$134.00
$34.67

Technical Indicators

Market Signals
Indicator
HALO
RTO
Relative Strength Index (RSI) 27.51 62.01
Support Level $64.08 $23.25
Resistance Level $111.15 $24.30
Average True Range (ATR) 4.64 0.38
MACD -3.78 0.04
Stochastic Oscillator 6.04 60.69

Price Performance

Historical Comparison
HALO
RTO

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

Share on Social Networks: